Correlation Between Alphabet and Arcturus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Alphabet and Arcturus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alphabet and Arcturus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alphabet Inc Class C and Arcturus Therapeutics Holdings, you can compare the effects of market volatilities on Alphabet and Arcturus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alphabet with a short position of Arcturus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alphabet and Arcturus Therapeutics.
Diversification Opportunities for Alphabet and Arcturus Therapeutics
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Alphabet and Arcturus is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Alphabet Inc Class C and Arcturus Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcturus Therapeutics and Alphabet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alphabet Inc Class C are associated (or correlated) with Arcturus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcturus Therapeutics has no effect on the direction of Alphabet i.e., Alphabet and Arcturus Therapeutics go up and down completely randomly.
Pair Corralation between Alphabet and Arcturus Therapeutics
Given the investment horizon of 90 days Alphabet Inc Class C is expected to generate 0.38 times more return on investment than Arcturus Therapeutics. However, Alphabet Inc Class C is 2.61 times less risky than Arcturus Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Arcturus Therapeutics Holdings is currently generating about 0.0 per unit of risk. If you would invest 10,657 in Alphabet Inc Class C on November 28, 2024 and sell it today you would earn a total of 6,884 from holding Alphabet Inc Class C or generate 64.6% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Alphabet Inc Class C vs. Arcturus Therapeutics Holdings
Performance |
Timeline |
Alphabet Class C |
Arcturus Therapeutics |
Alphabet and Arcturus Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Alphabet and Arcturus Therapeutics
The main advantage of trading using opposite Alphabet and Arcturus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alphabet position performs unexpectedly, Arcturus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcturus Therapeutics will offset losses from the drop in Arcturus Therapeutics' long position.The idea behind Alphabet Inc Class C and Arcturus Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Arcturus Therapeutics vs. 89bio Inc | Arcturus Therapeutics vs. Madrigal Pharmaceuticals | Arcturus Therapeutics vs. Pliant Therapeutics | Arcturus Therapeutics vs. Arcellx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |